Background The Nef protein of HIV-1 is suspected to play a role in the depletion of uninfected CD4
Introduction
Both the human (HIV-1) and the simian (SIV) immunodeficiency viruses are complex retroviruses whose genomes comprise many regulatory genes, namely tat, rev, vif, vpu, nef, vpr and vpx [1, 2] . Among them, vif, vpu, vpr and nef are not needed for virus replication in vitro and are therefore termed 'nonessential' [3] .
The nef gene is located at the 3 0 of env gene and partially overlaps the U3 region of the 3 0 LTR. The product of HIV-1 nef is a 27-30 kDa protein whose myristoylation at its N-terminus [4] permits its linkage to the cytoplasmic leaflet of the plasma membrane. However, perturbation of the lipid bilayers by the myristoylated protein also leads the carboxyl-terminal portion of Nef to protrude on the cell membrane [5] . Even so, infected lymphocytes usually express Nef in both their cytosol and nuclei and may also solubilize the protein by the cell membrane [6] [7] [8] .
The biological role of Nef on HIV-1 replication is controversial. In contrast to its in vitro inefficacy [9] [10] [11] [12] , recent studies have shown that the intact nef gene is pivotal in maintaining a high virus load in rhesus monkeys infected with the pathogenic SIVmac239 clone, and for the development of AIDS [13] . In addition, the wild-type nef gene from HIV-1 significantly increases the viral load in the SCID-Hu mouse model (a severe combined immunodeficient mouse transplanted with human fetal liver and thymus) [14] , whereas its mutated form showing a structural defect in 3 0 LTR sequences has been tentatively associated with long-term non-progression of the disease in HIV-1 infected subjects [15] . These observations suggested that nef gene and its product could be involved in the lymphocyte depletion that leads to AIDS. Demonstration of the suppressive effect of Nef on T-cell activation as well as the inhibition of CD4 þ cell growth [16] and the downregulation of both TCR-induced IL-2 production [17] , and activation of transcriptional factors NF-kB and AP-1 [18] has lent support to this interpretation. In addition, Th1 cytokine secretion is specifically suppressed in T cells incubated with Nef protein, whereas Th2 production is scarcely affected [19] .
Nef may directly exert a cytotoxic effect on CD4 þ cells by inducing their apoptosis [20, 21] , just as env [22] and tat [23] promote this in T cells and contribute to the development of CD4 þ lymphopenia. This hypothesis is supported by suppression of the in vitro proliferation of CD4 þ cells and the fact that membrane expression of the C-terminus domain of Nef in infected lymphocytes cocultured with unprimed T-cell lines activates their suicidal death [20, 21, 24] . Further investigations have suggested that the Nef-induced down-regulation of CD4 molecules correlates with the intracellular levels of Nef [25] , whereas its apoptogenic effect on T and B cells, macrophages and neutrophils during HIV-1 infection is apparently unrelated to the CD95/Fas pathway [26, 27] . Conversely, soluble Nef has been shown to induce considerable cellular activation as a result of its superantigen effect on MHC class II molecules [28, 29] .
This work studied the effect of Nef on peripheral lymphocytes from HIV-1 infected individuals at different stages. CD4 þ cells were clearly affected and underwent a variable degree of suppression, whereas CD8 þ cells showed an apparent increase in their proliferative rate, especially the CD8
þ cells which exhibit a prevalently suppressor phenotype. In addition, Nef inhibited both the expression of Fas-L on cytotoxic CD8 þ cells and the proliferation of HLA-DR þ lymphocytes, namely a population that suppresses HIV-1.
Methods

Plasmid construction
Full-length nef was amplified from pNL4-3 (kindly provided by Dr M. Federico, Laboratory of Virology, Istituto Superiore di Sanità, Rome, Italy) by polymerase chain reaction (PCR) using the primer pair covering the ATG and the 'stop codon' of the native nef sequence [4] . The amplification employed 25 cycles at 94 ЊC for 45 00 , 58 ЊC for 30 00 and 72 ЊC for 30 00 , respectively. The PCR product was then purified and cloned into pTracer eukaryotic expression vector (Invitrogen, Pero, Italy) to create pTracer-nef.
Cell lines and transfection procedures
In preparing the feeder layer expressing Nef for human lymphocyte cultures, we adopted a xenogeneic adherent cell line to avoid molecular interactions between syngeneic human cells potentially perturbing the cellular response. Therefore, we used the NIH-3T3 cells, a fibroblast line established from NIH Swiss mouse embryo cultures (ATCC, Rockville, Maryland, USA), which have been successfully employed in transfection studies exploring the response of human NK cells [30] . The 3T3 cells were grown in DMEM (at high glucose rate) medium supplemented with 10% FCS and L-glutamine and subsequently transfected with 5 mg of pTracer-nef by Lipofectamine (Gibco-BRL, Life Technologies Italia, San Giuliano Milanese, Italy) according to the manufacturer's instructions. After appropriate selection in G418 at 1 mg mL ¹1 , single clones were isolated and further analysed by RT-PCR to assess the quantitative expression of nef. We then selected nine clones showing high levels of nef RT-PCR product as evaluated by direct O.D. measurement after extraction from agarose gel (Concert TM Gel Extraction Kit, Gibco BRL, Milan, Italy). In addition, the membrane expression of Nef was estimated by flow cytometry with the anti-Nef monoclonal antibody (MoAb) AE6 (obtained from 'AIDS Research and Reference Reagent Program', Division of AIDS, NIAD, NIH, Bethesda MA, USA). Four clones (3T3-2, ¹3, ¹5, and ¹7) were positive for high membrane expression of Nef as demonstrated by a relative fluorescence intensity higher than one decade. Comparative experiments in preliminary tests in which peripheral blood lymphocytes (PBL) were incubated with each of the Nef-positive transfectants showed a major suppressive effect on CD8 þ subsets by the 3T3-7 transfectant. As the protein was expressed on the membrane of more than 95% of cells in this clone, we used the 3T3-7 transformant as adherent layer to culture lymphocytes.
PBL purification and coculturing with Nef-transfected cells
The study included 16 HIV-1 infected patients at different disease stages and 9 healthy donors. Seven patients were arbitrarily considered as severely lymphopenic (CD4 þ cells Յ300 mL
¹1
). PBL were purified from heparinized blood using Ficoll Hypaque gradient centrifugation and subsequent removal of adherent cells by incubation for 45 min at 37 ЊC. The cells were then washed and cultured at 1 × 10 6 mL ¹1 in 6-well plates containing the adherent 3T3-7 at 50-60% of confluency in RPMI-1640 plus 10% FCS in the presence of 1mg mL ¹1 interleukin (IL)-2. After 60 h of coculture, the nonadherent cells were harvested, washed and used for further analysis. To properly evaluate the effect of Nef, cellular analyses were compared in all instances to parallel cultures from each PBL sample of both patients and controls using nontransfected 3T3 cells as substrate.
Measurement of proliferation and apoptosis in cells stimulated by Nef
Proliferation was assessed by double fluorescence measurement of the expression of Ki67 antigen, in association with subset phenotyping with specific MoAbs to CD4, CD8, and CD16 antigens (Becton-Dickinson, Mountain View, CA, USA). Double fluorescence was also used to measure the size of the CD8 þ /CD57 þ subset in response to Nef. To evaluate apoptosis, cells were harvested and permeabilized by 70% ethanol for 1 h at þ4 ЊC prior to staining with propidium iodide at 50 mg mL ¹1 in PBS to detect subdiploid DNA [31, 32] . The extent of apoptosis was then expressed as the percentage of cells with subdiploid DNA. These analyses were conducted in a FACScan (Becton-Dickinson) using the CellQuest program.
Preparation of purified CD8
þ cell suspension and phenotype analysis
The effect of Nef on T-cell subsets was examined by purifying CD8 þ subsets from each PBL sample preincubated with nef-transfected cells and the relative control by immunomagnetic isolation using Dynabeads M-450 (Unipath, Milan, Italy). The full procedure recommended by the manufacturer was employed, providing a final enrichment of 92·3% of CD8 þ cells. Double fluorescence analysis then evaluated the expression of HLA-DR antigens, which define the activated phenotype of CD8 þ cells as response to the incubation with Nef.
Molecular analyses
In view of the proliferative response of CD8 þ cells to Nef, we measured the expression of Fas-L mRNA in purified CD8 þ populations, because Fas-L is a prevalent marker of cytotoxic cells (CTL) within this subset. Thus, mRNA was isolated from 1 × 10 6 CD8 þ cells in both unstimulated and Nef-stimulated cultures from 11 patients by the guanidium thiocyanate-cesium chloride procedure (Invitrogen, Celbio, Pero, Italy), and transcribed into first-strand cDNA with the Boehringer-Mannheim (Milan, Italy) cDNA kit. The Fas-L wild-type-specific primers were designed in relation to the known gene structure as follows: 5 0 -GCC CAA GCT TGA AGC AGC CCT-3 0 (FW), and 5 0 -TGC TGT GTG CAT CTG GTC GGT AGA-3 0 (RV) related to the exon-2 of the gene. Both primers and cDNA from each CD8 þ preparation were added to the PCR mixture (Perkin-Elmer, Cetus, Norwalk, Connecticut, USA) with subsequent amplification in a thermal cycler for 35 cycles (1 min 94 ЊC, 1 min 65 ЊC, 1 min 72 ЊC) and the Fas-L PCR product was visualized on a 1·5 agarose gel with ethidium bromide. Fas-L mRNA was estimated by evaluating the relative bands as 'trace quantity value' (o.d. × mm of each band) by Quantity-One 4·3 software in the Fluor-S gel analyzer (Bio-Rad Labs, Hercules, CA, USA).
Statistical analyses
Mean values of cellular subsets and phenotype expression between groups were compared by Student's t-test and, in several instances, by the Wilcoxon test as a nonparametric method.
Results
Nef induces a variable proliferation on PBL
Since Nef has been consistently reported to suppress T cells [16, 20, 21] , we first assessed the extent of apoptosis in PBL cultures from both HIV-1-infected patients and healthy controls after 60 h of incubation with the nef-3T3-7 transfectant. An apparent inhibition of apoptosis was noted in both groups of cultures. Nef induced a variable though significant decrease in the relative extent of the mean subdiploid DNA peaks (M1 Ϯ SD): 14·2 Ϯ 5% and 10·7 Ϯ 3% in Nef-treated cultures, as compared to 32·4 Ϯ 4% and 19·6 Ϯ 3% in untreated cultures from patients with severe (CD4 þ Յ 300 mL
¹1
) and moderate (> 300 mL ¹1 ) lymphopenia (P < 0·02 in both instances). The control cultures from uninfected donors showed a similar, though lower decline of apoptosis: mean M1 8·7 Ϯ 3% in Nef-stimulated vs. 14·6 Ϯ 3 in untreated cultures. However, this variation was not different in a statistical mode (P > 0·2). These data are in agreement, and were in apparent concordance with reference values from our previous work [32] , though the prolonged xenoantigen stimulation by 3T3 cells in increasing the PBL apoptosis independently of Nef cannot be excluded. Representative profiles of this down-modulated apoptosis in a patient with severe CD4 þ lymphopenia (Pt. # 1) and a control subject are shown in Fig. 1 . In both instances, the subdiploid DNA cell population was quantitatively reduced in cells harvested after incubation with the 3T3-7 clone (right panels). Morphological features of cell activation and proliferation, namely the expansion of both size and forward scatters, were also evident in both the euploid and the hyperdiploid cell populations gated in M2 and M3, respectively. These individual variations of fluorescence intensity were not statistically evaluated, though they were clearly detected in cells cultured in the presence of Nef and occurred in most preparations.
Further experiments were addressed to identify the cellular subset(s) with a prominent tendency to proliferate. Double fluorescence flow cytometry was used to measure Ki67 expression in CD16 þ , CD4 þ and CD8 þ subsets following a 60-h-culture with Nef. Table 1 shows the distribution of relative values of peripheral CD4 þ and CD8 þ cell counts in association with the effect of Nef in groups of cultures from patients and controls. Nef generally had little effect on the proliferation of CD16 þ and CD4
þ cells, because their mean values within each group showed a decrease, thus suggesting an apparent suppression. On comparing single values within each subset, however, it was found that patients with severe lymphopenia were variably affected in relative CD4 þ cell proliferation. Similarly, a proliferative decrease was prevalent in the uninfected controls and the mean values of suppression were significant (P < 0·02), thus confirming the susceptibility of uninfected cells to Nef-induced apoptosis [17, 21] . In contrast, a clear-cut trend to proliferation was detected in the CD8 þ subset. The increase of positive cells was higher in patients than in the controls and the difference between mean values was significant (P < 0·05 in both instances) in each group. We also recorded a moderate ) and in a normal subject. The fluorescence profiles are related to single subjects and show representative patterns for each group of cultures. Incubation of PBL in the presence of Nef (right panels) induced a major subset growth in cultures from lymphopenic patients, as in section (a), and a poor increase in those from nonlymphopenic patients (b) and healthy controls (c). Left panels refer to control cultures prepared with untransfected fibroblasts.
though not significant tendency to proliferation (P > 0·1) in cultures from healthy controls. þ lymphopenic patients (P < 0·01). In fact, the mean value of 16·8 Ϯ 4% of CD8 þ /CD57 þ cells in cultures from this group rose to 35·1 Ϯ 6% after incubation with Nef. Cell cultures from nonlymphopenic patients also showed a slight increment of mean levels (24·6 Ϯ 3% vs. 20·3 Ϯ 7% in unstimulated cultures), whereas no evident variations were observed in the control cultures from the uninfected donors (10·9 Ϯ 2% vs. 9·8 Ϯ 3% of CD8
A major proliferative effect is detectable in
þ cells in unstimulated cultures). 
/CD57
þ increase was doubled in the first patient, whereas it was small in the second. The pattern relative to the control shows that Nef has little effect on CD8 þ / CD57 þ population in cultures from healthy donors. These data suggested that Nef stimulation results in greater expansion of suppressor CD8 þ cells when CD4 þ cells are severely depleted as in the advanced stages of HIV-1 infection.
Nef down-regulates Fas-L expression in cytotoxic CD8
þ cells from HIV-1-infected patients
We next looked to assess whether or not Nef was able to affect the CD8 þ cells displaying the cytolytic phenotype (CTL). Fas-L expression was then explored in these cells by measuring the relative mRNA levels of purified CD8 þ cells from most patient cultures, five patients with severe and six with moderate lymphopenia. In addition, CD8 þ cells were harvested from the cultures of five healthy controls. We observed an apparent diminution of the Fas-L bands in Nef-exposed CD8 þ cells from all culture samples. Figure 3 illustrates this pattern in a representative subject from each group, namely from patients no. 4 and 15, and normal donor no. 6. The quantitative evaluation by the Fluor-S analyzer confirmed a general decrease of Fas-L expression after treatment with Nef (lanes b). We found a difference in the Fas-L mRNA trace quantity values, which were apparently higher in patients with severe CD4
þ lymphopenia (0·112 of mean reduction value as compared to 0·087 o.d. × mm of the other group of patients). However, these variations were not statistically evaluated in comparing groups of samples because of the high intragroup variability.
Suppressor anti-HIV-1 CD8 þ lymphocytes are inhibited by Nef
Lastly, the role of Nef on noncytotoxic HIV-1-specific suppressor CD8
þ lymphocytes in cultures from HIV-1-infected subjects was examined. This anti-HIV-1 response appears to be associated primarily with activated CD8 þ cells expressing both HLA-DR and CD28 antigens and acts through a soluble inhibitory factor termed CAF (CD8 þ T-cell antiviral factor) [33] . Therefore, our analysis investigated the effect of Nef on this specific subset by measuring in double fluorescence the expression of HLA-DR molecules in purified CD8 þ cells from four patients with severe and 5 with moderate lymphopenia. Nef down-regulated HLA-DR in most cultures. Patients with the lowest CD4 þ levels showed a significant suppression of their CD8 þ /HLA-DR þ population in response to Nef: the mean number declined from 32·9 Ϯ 8 to 15·1 Ϯ 7 (P < 0·02). A similar effect was also observed in single patients with moderate CD4 þ lymphopenia. However, although the decrement of the mean value of HLA-DR þ cells ranged from 37·6 Ϯ 4% in untreated cultures to 32·1 Ϯ 6% in the presence of Nef, it was not statistically significant (P > 0·2). Figure 4 reports the cytofluorimetric pattern of two patients from each group and gives an example of the suppressive effect of Nef on these cells, which was higher than 50% in the CD8 þ population of both patients with severe CD4
þ lymphopenia (section a). Similarly, a lower suppression of proliferation was demonstrable in both patients with moderate lymphopenia (section b), whose average value was about 5%, and reflected the results of other patients with similar CD4 þ cell levels. Lastly, Table 2 includes the variations of mean values in fluorescence intensity of DR expression following treatment with Nef. In most instances we observed a variable suppression of DR antigens in CD8 þ cells incubated with Nef. However, such variations of relative fluorescence intensity in DR expression were not calculated in statistical terms because of the small number of samples. These results suggested that activated anti-HIV-1 suppressor CD8 þ cells could be directly inhibited by Nef in culture.
Discussion
Our study on the effect of Nef on CD8 þ cells during HIV-1 infection has shown that, in addition to its cytolytic effect on other T cells, it stimulates the growth of CD8 þ /CD57 þ subset in vitro, and down-modulates both the expression of Fas-L, a death factor of CTLs, and the proliferation of CD8 þ cells activated to HIV-1; namely the CD8 þ /HLA-DR þ subset. These immune dysfunctions of CD8 þ cells are significant in patients with severe lymphopenia and probably contribute to the progression of HIV-1 infection to AIDS.
Recent work has provided new insights into the function of Nef during HIV-1 disease. Originally seen as a negative regulator for virus replication [9] it is now being shown to play a positive role in replicating HIV-1 in primary T cells and T-cell lines [34] [35] [36] . It also down-regulates cell surface levels of CD4 molecules [37, 38] and induces cytolysis of CD4 þ cells in either its soluble [21] or its myristoylated form [20, 24] . Although the myristoylated Nef peptide is anchored on the internal sheet of the plasma membrane by the N-terminal glycine, the myristoylation procedure induces a disordering effect on the lipid bilayers, resulting in nonlamellar phases of the whole membrane layer and extrusion of the other terminal portion of the viral protein [39] [40] . Exhibition of the carboxy-terminal domain of Nef on the HIV-1-infected T-cell surface is critical in provoking cell death by cytotoxicity in uninfected CD4
þ lymphocytes [5, 24] , whereas interaction of Nef with specific cellular kinases has suggested that it interferes with signalling pathways that promote T-cell activation [41] . Our present study emphasizes that, in contrast with the down-regulation of CD16 þ and CD4 þ cells, the myristoylated form of Nef from nef-3T3-7 transfectant induces a number of functional defects within the CD8 þ subset that may promote the escape of both HIV-1 and infected cells from immune control. However, as it has been reported that soluble Nef may affect proliferation of CD4 þ cells [21] , further cellular suppression by soluble Nef molecules possibly released in our cultures by either transfected fibroblasts or infected cells cannot be ruled out. The first derangement induced by Nef concerns the increase of CD8 þ /CD57 þ cells. This subset is phenotypically distinct because of its prevalent suppression of B-cell differentiation, proliferation and Ig secretion [42, 43] . Although no specific antiviral cytotoxicity has been attributed to this population [44] , its oligoclonal expansion occurs in several clinical conditions including cytomegalovirus infection [45] , Crohn's disease [46] , common variable immunodeficiency [47] , and HIV-1 infection [48] . In this disease as well as in the immune deficiency of bone marrow transplantation recipients [49] , suppression was related to a 20-kDa, heat-stable suppressor factor [50] that inhibits lectin-driven proliferation and cytolysis [51] . In our study, we observed that a broad expression of Ki67 antigen was presented by CD8 þ cells cultured in the presence of Nef and paralleled the expansion of the CD57 þ cell subset, in particular in patients with severe CD4 þ lymphopenia. By contrast, mostly stable or weakly increased values of CD57 þ cells were detected in cultures from moderately lymphopenic patients and the controls. We interpreted the differential proliferative response to Nef as a result of the divergent levels of CD4 Our study also points to the down-regulation of Fas-L expression in cytotoxic CD8 þ cells treated with Nef. Fas-L is the functional coreceptor of Fas and induces apoptosis in Fas þ target cells by oligomerization of the receptor. This mechanism is used by most effector cells and Fas-L is considered a major phenotypic marker of CTLs. The apparent down-modulation of mRNA in treated cells in our study was in line with the relative increase of the CD57 þ subset, especially in patients with severe lymphopenia. As Nef-induced cytolysis of uninfected lymphocytes is independent of Fas/Fas-L system [26, 27] , this finding supports the view that the viral protein does not act through the Fas/Fas-L pathway. On the other hand, similarly defective Fas-L mRNA expression has been described in advanced HIV-1 infection [52] [53] [54] , suggesting that the antigenic charge of soluble Nef may partly contribute to Fas-L down-regulation, though defective CTL function in this disease could be the result of the increased suppression by CD57 þ cells [45, 48] . Our study, in fact, documented CD57 þ expansion in advanced infection following exposure to Nef, though its suppression of Fas-L via other mechanisms cannot be excluded.
Another interesting finding was the detrimental effect of Nef on HIV-1 suppressor CD8 þ lymphocytes resulting in a defective expression of HLA-DR molecules. These data are in apparent contrast with the increase of Ki67 þ cells within the same subset. However, previous studies have pointed out a possible discrepancy between both cell cycle and activation antigen expression in CD4 þ and CD8 þ T cells in patients receiving the HAART (highly active antiretroviral treatment) therapy, especially during the chronic HIV-1 infection [55] [56] . In particular, though in the presence of a proliferative trend involving the total T-cell population, activation of CD8 þ T cells measured by both CD38 and HLA-DR expression was significantly affected in this subset [57] . Our results showing a similar inhibition of HLA-DR molecules in response to Nef in patients with advanced disease are in line with these observations. On the other hand, CD8 þ cells expressing both HLA-DR and CD28 markers are thought to suppress HIV-1 replication by CAF in CD4 þ lymphocytes and macrophages [33] . We observed an evident decline of this population in cultures treated with Nef. Suppression of HIV-1 replication by CAF in naturally or acutely infected CD4 þ cells has been described as dose-dependent and correlated with clinical state and CD4 þ cell levels in peripheral blood [58] . Although we did not measure the extent of CAF secretion in cultures, the depletion of HLA-DR þ cells after incubation with Nef suggests a parallel reduction in the release of the suppressive factor, particularly in patients with advanced disease.
Our data on the effect of Nef on CD8 þ cells support recent studies describing its multifactorial role in the depletion of immune cells during HIV-1 infection. In addition to its cytolysis of uninfected CD4 þ lymphocytes, Nef may down-regulate the MHC class I on infected cells to promote their escape from cytolysis of functional CTLs [59] . In this context, its down-modulation of their expression of Fas-L and its inhibition of suppression by non cytotoxic anti-HIV-1 CD8 þ cells are ways of escaping immune surveillance. Additional work is required to investigate the molecular defects of such Nef-related deregulations of CD8 þ cells, though they may be the multiple outcome of a single deviation primarily induced by either soluble or myristoylated Nef. For instance, alteration in the secretion of CD8 þ cell cytokines could be a primary event leading to differentiated dysfunctions within the subset. Preliminary data from our laboratory support this hypothesis, in that CD8 þ /CD57 þ cells treated with Nef showed high mRNA expression of several suppressive cytokines, including IFN-g and IL-4, which could significantly influence both Fas-L expression in CTLs and CAF secretion in activated CD8 þ cells.
